Actively Recruiting
Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
Led by China Medical University Hospital · Updated on 2024-12-02
110
Participants Needed
1
Research Sites
29 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are: What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.
CONDITIONS
Official Title
Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with acute cerebrovascular disease within 1 month after stroke
- Stable neurological condition without deterioration for over 72 hours
- Stable or controllable vital signs including blood pressure, heartbeat, and body temperature for over 72 hours
- No complications like infection, blood abnormalities, or gastrointestinal bleeding, or stable/controlled after treatment
- Moderate to moderately severe functional impairment (Modified Rankin Scale 3-4) with active rehabilitation potential
- Basic cognition, learning ability, and willingness to participate
- Physical strength to sit supported on wheelchair or bed edge for at least one hour
- Ability to actively participate in rehabilitation treatment plans
- Age over 20 years old
You will not qualify if you...
- Atrial fibrillation or arrhythmia
- Within 2 weeks after cardiac catheterization or femoral artery puncture
- Decompensated heart failure (NYHA class 3 or 4)
- Left ventricular ejection fraction less than 30%
- Moderate or severe aortic regurgitation
- Persistent uncontrolled high blood pressure (over 160/100 mmHg)
- Bleeding tendency
- Active phlebitis or venous disease in lower limbs
- Severe vascular blockage in lower limbs
- Documented aortic aneurysm or dissection needing surgery
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Medical University Hospital Taichung East District Branch
Taichung, Taiwan
Actively Recruiting
Research Team
L
Li-Wei Chou, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here